leisure time -WSS

leisure time

author：fashion 2025-09-30 00:36:21 - browse：85

To much of the public, the promise of telehealth is all about convenience — get the prescription you need quickly, and get it delivered right to your door. But as digital health companies build out their weight loss businesses, capitalizing on the popularity of drugs like Wegovy and Ozempic, they’re courting a very different audience: payers and employers who have a vested interest in preventing quick scripts.

Payers are reeling as they try to figure out how to sustainably cover GLP-1 receptor agonists, a class of remarkably effective but expensive obesity and type 2 diabetes drugs. So in the last six months, digital health companies including Teladoc, Found, Hello Alpha, and Calibrate have advanced enterprise products that pair virtual visits and prescriptions with lifestyle coaching. Their hope is that more and more payers and employers will offer their programs as a way to support lasting weight loss and metabolic health — or even require them if patients want their drugs reimbursed.

The competition is growing quickly. Telehealth companies once focused exclusively on consumers are now marketing to payers. Enterprise programs for chronic care management are promoting new services to support patients on obesity drugs. And companies like Noom and WeightWatchers, which have built gargantuan weight loss businesses for consumers and businesses alike, are starting to prescribe the drugs.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Cord blood banking comes at a high cost to babies

WSS

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

Readout Newsletter: Nvidia, Biogen, Ionis, AstraZeneca, ChatGPT

Bird flu: Don't repeat Covid's 'health versus the economy' framing

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Venture capitalist Bob Kocher on the state of digital health

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Wikipedia

leisure time

explore

Affirmative action in medical school literally saved lives

NVIDIA and Google execs on the future of AI and drug discovery

After affirmative action ruling, medical educators look to 'holistic review'

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

The cancer drug shortage isn’t new — and neither are the solutions

Cytokinetics CEO stresses company can launch heart drug on its own

Guidelines to prevent youth baseball injuries need more muscle

At ASCO, pharma leaders speak of advances in 'smart bomb' drugs

Continuity nursing helped my family in our darkest PICU moments

Criminal prosecution for violating HIPAA: an emerging threat

Wikipedia

How to increase colonoscopy rates? Looks like an AI can help

Venture capitalist Bob Kocher on the state of digital health

Cord blood banking comes at a high cost to babies

Criminal prosecution for violating HIPAA: an emerging threat

It's time to retire 'poor historian' from clinicians' vocabularies

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

focus

hotspot

explore

Wikipedia